Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.

Progress in neuro-psychopharmacology & biological psychiatry - 8 Jun 2018

Angyal Nora, Horvath Erzsebet Zsofia, Tarnok Zsanett, Richman Mara J, Bognar Emese, Lakatos Krisztina, Sasvari-Szekely Maria, Nemoda Zsofia

Abstract excerpt

AIMS: Methylphenidate (MPH) is the most frequently prescribed drug in Attention Deficit Hyperactivity Disorder (ADHD). Hitherto mostly the dopamine transporter gene has been studied in MPH-response and only a few studies analyzed the norepinephrine transporter (NET, SLC6A2) gene, although MPH is a potent inhibitor of both dopamine and norepinephrine transporters. We aimed to analyze this monoamine transporter...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Attention
Share to Attention Deficit Disorder with Hyperactivity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Central Nervous System Stimulants

Share to Introns

Share to Linkage Disequilibrium

Share to Methylphenidate

Share to Norepinephrine Plasma Membrane Transport Proteins

Share to Pharmacogenomic Variants

Source

Identifiers

PMID: 29374517
DOI: 10.1016/j.pnpbp.2018.01.013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.PMID 29374517Read ↗

Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder.Semantic proximity Read ↗

Norepinephrine transporter gene (SLC6A2) is involved with methylphenidate response in Korean children with attention deficit hyperactivity disorder.Semantic proximity Read ↗

A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.Semantic proximity Read ↗

Association of norepinephrine transporter gene with methylphenidate response.Semantic proximity Read ↗

Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Association of SNAP-25, SLC6A2, and LPHN3 with OROS methylphenidate treatment response in attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD.Semantic proximity Read ↗

No significant association between genetic variants in 7 candidate genes and response to methylphenidate treatment in adult patients with ADHD.Semantic proximity Read ↗

Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).Semantic proximity Read ↗

Role of the norepinephrine transporter polymorphisms in atomoxetine treatment: From response to side effects in children with ADHD.Semantic proximity Read ↗

Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD.Semantic proximity Read ↗

Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.